All In Biotech

Drug Trial Radar · NCT07218341

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Long-Term Safety of Pirtobrutinib in Participants From Study LOXO-BTK-20020 With BTKi Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Mar 9, 2026

Primary completion

May 2030

Study completion Dec 2032

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Oct 20, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the long-term safety of pirtobrutinib in participants with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The study is open to those who completed J2N-MC-JZNN/LOXO-BTK-20020 (NCT 04666038) for continued access to the study intervention or continued follow-up visits. Treatment will be given every 4 weeks and this study is expected to last about 5 years.

Conditions

  • Chronic Lymphocytic Leukemia
  • Lymphoma, Small Lymphocytic

Interventions

  • PirtobrutinibDrug

    Administered orally

  • IdelalisibDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants with a Grade 3 or Higher Treatment-emergent Adverse Events (AEs)Time frame: Time from First Dose of Study Intervention (Study Day 1) through 30 Days After Last Dose of Study Intervention or Start of New Anticancer Therapy, whichever is Earlier

Locations

50 sites in 17 countries. Site status is shown where the registry gives one.

  • Mitchell Cancer Institute

    Mobile, Alabama · Recruiting

  • Arizona Oncology Associates, P.C. - HOPE

    Tucson, Arizona · Not yet recruiting

  • Cancer Specialists, LLC

    Jacksonville, Florida · Recruiting

  • Minnesota Oncology Hematology, P.A.

    Coon Rapids, Minnesota · Recruiting

  • Cayuga Cancer Center

    Ithaca, New York · Not yet recruiting

  • Memorial Sloan-Kettering Cancer Center (MSKCC) - New York

    New York, New York · Recruiting

  • Oncology Hematology Care Inc

    Cincinnati, Ohio · Recruiting

  • Texas Oncology - Paris

    Fort Worth, Texas · Recruiting

  • US Oncology - Texas Oncology

    Kyle, Texas · Recruiting

  • The Alfred Hospital

    Melbourne, Australia · Recruiting

  • LKH - Universitätsklinikum der PMU Salzburg

    Salzburg, Austria · Not yet recruiting

  • AZ Delta

    Roeselare, Belgium · Not yet recruiting

  • Princess Margaret Cancer Centre - University Health Network

    Toronto, Canada · Not yet recruiting

  • Xuanwu Hospital Capital Medical University

    Beijing, China · Not yet recruiting

  • Hunan Cancer Hospital

    Changsha, China · Not yet recruiting

  • Sun Yat-sen University Cancer Center

    Guangdong, China · Recruiting

  • Nanfang Hospital of Southern Medical University

    Guangzhou, China · Recruiting

  • Gansu Provincial Cancer Hospital

    Lanzhou, China · Not yet recruiting

  • The First Affiliated Hospital of Nanchang University

    Nanchang, China · Recruiting

  • Fudan University Shanghai Cancer Center

    Shanghai, China · Not yet recruiting

  • Taizhou Hospital of Zhejiang Province

    Taizhou, China · Recruiting

  • Hematology Hospital of the Chinese Academy of Medical Sciences

    Tianjin, China · Recruiting

  • Tianjin Medical University Cancer Institute & Hospital

    Tianjin, China · Recruiting

  • Affiliated Cancer Hospital of Xinjiang Medical University

    Ürümqi, China · Not yet recruiting

  • The Affiliated Hospital of Xuzhou Medical College

    Xuzhou, China · Recruiting

  • Henan Cancer Hospital

    Zhengzhou, China · Not yet recruiting

  • University Hospital Center Zagreb

    Zagreb, Croatia · Not yet recruiting

  • Fakultni nemocnice Hradec Kralove

    Hradec Králové, Czechia · Not yet recruiting

  • Centre Henri Becquerel

    Rouen, France · Not yet recruiting

  • Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet

    Budapest, Hungary · Not yet recruiting

  • Debreceni Egyetem

    Debrecen, Hungary · Not yet recruiting

  • St. James's Hospital

    Dublin, Ireland · Not yet recruiting

  • Beaumont Hospital

    Dublin, Ireland · Not yet recruiting

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel · Not yet recruiting

  • Azienda Ospedaliero - Universitaria Nazionale Santi Antonio e Biagio e Cesare Arrigo

    Alessandria, Italy · Not yet recruiting

  • Azienda Ospedaliera Universitaria Careggi

    Florence, Italy · Recruiting

  • Presidio Ospedaliero Papardo

    Messina, Italy · Not yet recruiting

  • Fondazione IRCCS San Gerardo dei Tintori

    Monza, Italy · Not yet recruiting

  • Azienda Ospedaliera di Perugia Ospedale S. Maria della Misericordia

    Perugia, Italy · Not yet recruiting

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Rome, Italy · Recruiting

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.